Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Mar 27, 2020 · 10-K · 87 days after period end · 0001401914-20-000042
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 |
|---|---|---|---|---|
| Revenue | — | — | — | $766.00K |
| Net Income | -$3.87M | -$2.92M | -$9.13M | -$4.95M |
| EPS Diluted | — | — | — |
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
| -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2019 · filed Mar 27, 2020 · 87 d after period end
